Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 11:02 PM
Study NCT ID:
NCT01235793
Status:
TERMINATED
Last Update Posted:
2018-11-20
First Post:
2010-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
Sponsor:
Cedars-Sinai Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-05
First Submit QC Date:
None
Study First Post Date:
2010-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-25
Results First Submit QC Date:
None
Results First Post Date:
2018-11-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-23
Last Update Post Date:
2018-11-20
Last Update Post Date Type:
ACTUAL